Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964353 · ClinicalTrials.gov registry record · Phase 4
Clinical and Economic Implications of Genetic Testing for Warfarin Management
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 359
- Enrollment target
NCT00964353 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 359 participants.
The verdict
NCT00964353, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 359 participants
- Enrollment target
Study Summary
The purpose of this study is to explore how knowing genes that individuals inherit from their parents can make warfarin dosing more safe and effective. This study is being done to determine whether providing doctors with data on the genes their patients inherited and warfarin dosing recommendations based on those genes affects the costs and outcomes of care and after hospitalization for patients from different ethnic/racial backgrounds, and how physicians use this information in decision making.
Interventions
- DRUG Warfarin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 359 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00964353
The ClinicalTrials.gov registry entry for NCT00964353 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 359 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Warfarin is the first listed.
NCT00964353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00964353 about?
NCT00964353 is a clinical study titled "Clinical and Economic Implications of Genetic Testing for Warfarin Management". The purpose of this study is to explore how knowing genes that individuals inherit from their parents can make warfarin dosing more safe and effective. This study is being done to determine whether providing doctors with data on the genes their patients inherited and warfarin dosing recommendations ...
What is the current status of trial NCT00964353?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 359 participants. The study started on 2009-08. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00964353?
The interventions under investigation include: Warfarin (DRUG).
Who is sponsoring clinical trial NCT00964353?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.